Sanofi Reports Strong Malaria Vaccine Trial Results in West Africa
French pharmaceutical company Sanofi has reported Phase Two trial results showing eighty percent efficacy for a new malaria vaccine among children in West Africa and plans to accelerate regulatory submissions.